CDC warns access to ADHD meds may be disrupted after arrests of health-care startup executives
CNN
People taking medications for ADHD, or attention-deficit hyperactivity disorder, may face disruptions in accessing treatment after the arrests of two executives of a telehealth company that distributed such drugs to adults across the United States.
People taking medications for ADHD, or attention-deficit hyperactivity disorder, may face disruptions in accessing treatment after the arrests of two executives of a telehealth company that distributed such drugs to adults across the United States. On Thursday, the US Centers for Disease Control and Prevention issued an official health advisory warning about a “potential disrupted access to care among individuals taking prescription stimulant medications and possible increased risks for injury and overdose.” Around the same time, the US Department of Justice announced a federal health-care fraud indictment against two executives from the digital health company Done Global, whose website describes it as “making high quality psychiatric chronic care management more accessible and affordable for patients.” The indictment’s effect on patients “is unknown at the time,” according to the CDC’s advisory. “Patients who rely on prescription stimulant medications to treat their ADHD and have been using this or other similar subscription-based telehealth platforms could experience a disruption to their treatment and disrupted access to care,” the advisory said. “A disruption involving this large telehealth company could impact as many as 30,000 to 50,000 patients ages 18 years and older across all 50 U.S. states.” Ruthia He, the founder and CEO of Done Global Inc., was arrested in Los Angeles on Thursday and accused of participating in a scheme to distribute Adderall over the internet, conspire to commit health-care fraud and obstruct justice, according to the Justice Department’s announcement. The company’s clinical president, David Brody, also was arrested in San Rafael, California.
Deep within the Arctic Circle, pocketed between giant glaciers and beneath polar ice floes, photographer and content creator Cecilia Blomdahl finds extraordinary warmth.
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter decongestants – from the market, citing evidence that it doesn’t work.
Researchers are uncovering deeper insights into how the human brain ages and what factors may be tied to successful cognitive aging ((is successful the best word to use? seems like we’ll all do it successfully but for some people it may be healthier or gentler or slower?)), including exercising, avoiding tobacco, speaking a second language or even playing a musical instrument.
Chanel presented its Cruise 2024-2025 collection in Hong Kong on Tuesday, with a mix of light tweed suits, chic diving hoods and summery white dresses transporting guests to what the French label described as an “underwater reverie.”
The holiday season is nearly upon us and it’s easy for a child’s sweet tooth go wild. However, new research shows that it may be beneficial to cut back how much sugar young children consume.
Kardashian debuted a cultural artifact at Saturday’s LACMA Art+Film Gala – a diamond-lined cross pendant, once a favorite of Princess Diana.
She has been a UNICEF ambassador, a special envoy for Japan’s Foreign Ministry and the subject of themed restaurants, cafes, two amusement parks and even a maternity hospital.
Robert F. Kennedy Jr. waded into another scientific debate on Saturday by saying Donald Trump’s administration would advise that fluoride be removed from the country’s water supplies if the former president wins Tuesday’s presidential election.
Scientists say the fact that these cases were linked and solved so quickly makes it a noteworthy win.
The most hotly anticipated costume of the spooky season is here — and the “Queen of Halloween” didn’t disappoint.